Drug class
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody; Monoclonal antibody / antibody–drug conjugate
Mechanism of action
Fusion Protein Inhibitors [MoA]
General use cases
- respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season
- RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
